Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2018 October;70(5) > Minerva Pediatrica 2018 October;70(5):488-92

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW   

Minerva Pediatrica 2018 October;70(5):488-92

DOI: 10.23736/S0026-4946.17.04781-8

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

High-flow nasal cannula therapies for respiratory management in pediatric patients

Gang LIU, Conghai FAN , Hongwei WU

Department of Neonatology, Xuzhou Children’s Hospital, Xuzhou, China



High-flow nasal cannula (HFNC) oxygen therapy is a non-invasive form of respiratory support that is rapidly being taken up in pediatric intensive care units (PICU). For infants with bronchiolitis, who are the largest non-elective source of admissions to a PICU, there is some evidence that using HFNC therapy reduces the need for intubation and mechanical ventilation. The aim of this review article is to explore, describe, critique and add to the evidence surrounding the use of HFNC therapy in the pediatric population for the management of respiratory distress.


KEY WORDS: Cannula - Airway management - Pediatrics - Bronchiolitis - Respiration disorders

top of page